batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Syndax outlines a path to profitability 5 August 2025 Nuvectis switches focus 1 August 2025 Sanofi comes up against a graft-versus-host disease rock 1 August 2025 AbbVie reveals its bispecific interest 1 August 2025 Daiichi rekindles its sting 31 July 2025 No starring role for GSK’s Tim-3 30 July 2025 Lilly’s Jaypirca bests Imbruvica 30 July 2025 Exelixis’s son of Cabometyx disappoints again 30 July 2025 Load More